{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Anagrelide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Anagrelide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Anagrelide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "anagrelide",
    "trial_2_text": "Anagrelide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Anagrelide Supplement: 60 participants will take Anagrelide 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Anagrelide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Anagrelide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.34966105222702026,
      "123": 0.2520769238471985,
      "78": 0.22114481031894684,
      "64": 0.2132279872894287,
      "21": 0.20816123485565186,
      "228": 0.20449984073638916,
      "9": 0.18098142743110657,
      "17": 0.17677189409732819,
      "20": 0.17249256372451782,
      "46": 0.17181143164634705,
      "189": 0.1696769893169403,
      "188": 0.16224421560764313,
      "67": 0.16011837124824524,
      "2": 0.15392090380191803,
      "173": 0.14850296080112457,
      "37": 0.14727993309497833,
      "49": 0.13472644984722137,
      "191": 0.13215941190719604,
      "126": 0.1290312558412552,
      "350": 0.1269841194152832,
      "68": 0.12556304037570953,
      "177": 0.12504395842552185,
      "14": 0.12402364611625671,
      "101": 0.11759088188409805,
      "77": 0.11684264242649078,
      "114": 0.11479247361421585,
      "243": 0.1098547875881195,
      "29": 0.10948091000318527,
      "200": 0.10616519302129745,
      "239": 0.1044846624135971,
      "18": 0.10246619582176208,
      "179": 0.10116969794034958,
      "27": 0.10026154667139053,
      "104": 0.09699083119630814,
      "76": 0.09405592083930969,
      "193": 0.09103190153837204,
      "396": 0.08976522088050842,
      "5": 0.08836726099252701,
      "85": 0.08742956817150116,
      "136": 0.08605381101369858,
      "30": 0.0840761661529541,
      "194": 0.08288590610027313,
      "253": 0.0824916660785675,
      "79": 0.08148586750030518,
      "72": 0.08083202689886093,
      "282": 0.07975779473781586,
      "121": 0.0792756974697113,
      "249": 0.0759865790605545,
      "288": 0.07578699290752411,
      "61": 0.07546066492795944,
      "180": 0.0737728476524353,
      "151": 0.0737202987074852,
      "147": 0.0732279121875763,
      "86": 0.07316337525844574,
      "261": 0.07269378751516342,
      "35": 0.07234036177396774,
      "82": 0.07232996076345444,
      "131": 0.07200838625431061,
      "116": 0.07029721140861511,
      "441": 0.06939474493265152,
      "269": 0.06742340326309204,
      "276": 0.06682410091161728,
      "122": 0.06512625515460968,
      "355": 0.06437999755144119,
      "28": 0.06434476375579834,
      "382": 0.0635542944073677,
      "38": 0.0634288638830185,
      "257": 0.06255735456943512,
      "356": 0.06087186932563782,
      "211": 0.059779420495033264,
      "286": 0.05961008742451668,
      "96": 0.0594787523150444,
      "102": 0.058645110577344894,
      "212": 0.05839402228593826,
      "33": 0.057715702801942825,
      "142": 0.05632007122039795,
      "4": 0.055900827050209045,
      "139": 0.0557151697576046,
      "466": 0.055035125464200974,
      "98": 0.054289400577545166,
      "361": 0.05372871086001396,
      "15": 0.05323679745197296,
      "36": 0.05299017205834389,
      "69": 0.05124861001968384,
      "455": 0.05114586278796196,
      "204": 0.05008423700928688,
      "186": 0.04990525171160698,
      "213": 0.04944189637899399,
      "130": 0.04893142357468605,
      "187": 0.048645734786987305,
      "152": 0.047427497804164886,
      "144": 0.046733222901821136,
      "339": 0.04636959359049797,
      "31": 0.04633544757962227,
      "503": 0.04597150906920433,
      "371": 0.04519924148917198,
      "292": 0.04501517489552498,
      "400": 0.04470266401767731,
      "234": 0.04468050226569176,
      "1": 0.04434095323085785
    },
    "trial_2_ae": {
      "87": 0.34966105222702026,
      "123": 0.2520769238471985,
      "78": 0.22114481031894684,
      "64": 0.2132279872894287,
      "21": 0.20816123485565186,
      "228": 0.20449984073638916,
      "9": 0.18098142743110657,
      "17": 0.17677189409732819,
      "20": 0.17249256372451782,
      "46": 0.17181143164634705,
      "189": 0.1696769893169403,
      "188": 0.16224421560764313,
      "67": 0.16011837124824524,
      "2": 0.15392090380191803,
      "173": 0.14850296080112457,
      "37": 0.14727993309497833,
      "49": 0.13472644984722137,
      "191": 0.13215941190719604,
      "126": 0.1290312558412552,
      "350": 0.1269841194152832,
      "68": 0.12556304037570953,
      "177": 0.12504395842552185,
      "14": 0.12402364611625671,
      "101": 0.11759088188409805,
      "77": 0.11684264242649078,
      "114": 0.11479247361421585,
      "243": 0.1098547875881195,
      "29": 0.10948091000318527,
      "200": 0.10616519302129745,
      "239": 0.1044846624135971,
      "18": 0.10246619582176208,
      "179": 0.10116969794034958,
      "27": 0.10026154667139053,
      "104": 0.09699083119630814,
      "76": 0.09405592083930969,
      "193": 0.09103190153837204,
      "396": 0.08976522088050842,
      "5": 0.08836726099252701,
      "85": 0.08742956817150116,
      "136": 0.08605381101369858,
      "30": 0.0840761661529541,
      "194": 0.08288590610027313,
      "253": 0.0824916660785675,
      "79": 0.08148586750030518,
      "72": 0.08083202689886093,
      "282": 0.07975779473781586,
      "121": 0.0792756974697113,
      "249": 0.0759865790605545,
      "288": 0.07578699290752411,
      "61": 0.07546066492795944,
      "180": 0.0737728476524353,
      "151": 0.0737202987074852,
      "147": 0.0732279121875763,
      "86": 0.07316337525844574,
      "261": 0.07269378751516342,
      "35": 0.07234036177396774,
      "82": 0.07232996076345444,
      "131": 0.07200838625431061,
      "116": 0.07029721140861511,
      "441": 0.06939474493265152,
      "269": 0.06742340326309204,
      "276": 0.06682410091161728,
      "122": 0.06512625515460968,
      "355": 0.06437999755144119,
      "28": 0.06434476375579834,
      "382": 0.0635542944073677,
      "38": 0.0634288638830185,
      "257": 0.06255735456943512,
      "356": 0.06087186932563782,
      "211": 0.059779420495033264,
      "286": 0.05961008742451668,
      "96": 0.0594787523150444,
      "102": 0.058645110577344894,
      "212": 0.05839402228593826,
      "33": 0.057715702801942825,
      "142": 0.05632007122039795,
      "4": 0.055900827050209045,
      "139": 0.0557151697576046,
      "466": 0.055035125464200974,
      "98": 0.054289400577545166,
      "361": 0.05372871086001396,
      "15": 0.05323679745197296,
      "36": 0.05299017205834389,
      "69": 0.05124861001968384,
      "455": 0.05114586278796196,
      "204": 0.05008423700928688,
      "186": 0.04990525171160698,
      "213": 0.04944189637899399,
      "130": 0.04893142357468605,
      "187": 0.048645734786987305,
      "152": 0.047427497804164886,
      "144": 0.046733222901821136,
      "339": 0.04636959359049797,
      "31": 0.04633544757962227,
      "503": 0.04597150906920433,
      "371": 0.04519924148917198,
      "292": 0.04501517489552498,
      "400": 0.04470266401767731,
      "234": 0.04468050226569176,
      "1": 0.04434095323085785
    }
  },
  "safety": {
    "trial_1_safety": 0.5121882557868958,
    "trial_2_safety": 0.5121882557868958
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47622358798980713
  }
}